Get the Stockscreener App
1.37
1.08%
-0.02
Alector Inc stock is traded at $1.37, with a volume of 408.23K.
It is down -1.08% in the last 24 hours and up +10.89% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.39
Open:
$1.39
24h Volume:
408.23K
Relative Volume:
0.16
Market Cap:
$150.08M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.1138
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
+5.77%
1M Performance:
+10.89%
6M Performance:
-9.54%
1Y Performance:
-27.25%
1-Day Range:
$1.365
$1.415
1-Week Range:
$1.29
$1.54
52-Week Range:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.375 | 151.72M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
451.72 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.46 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
868.71 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.59 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
199.79 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Alector (ALEC) and Novan (NOVN) - The Globe and Mail
Alector (ALEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Alector appoints Neil Berkley as chief financial officer - MSN
How currency fluctuations impact Alector Inc stockMarket Trend Report & Expert Approved Momentum Trade Ideas - moha.gov.vn
Rate Cut: Is Alector Inc stock a safe investment in uncertain marketsTrade Entry Summary & Smart Swing Trading Techniques - moha.gov.vn
Alector (ALEC) Appoints Neil Berkley as CFO - GuruFocus
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer - The Manila Times
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer - Quiver Quantitative
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer | Associated Press | syndication news - Enidnews.com
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer, Effective December 10, 2025 - marketscreener.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - MSN
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - MSN
Is Alector Inc a good long term investmentTrading Psychology Tips & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Alector principal accounting officer Wong-Sarad sells $5,751 in stock By Investing.com - Investing.com South Africa
Alector principal accounting officer Wong-Sarad sells $5,751 in stock - Investing.com
Transcript : Alector, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 02 - marketscreener.com
Performance Recap: What valuation ratios show for Alector Inc 0Z2 stockStock Surge & Fast Entry Momentum Trade Alerts - moha.gov.vn
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
How the Narrative Surrounding Alector Has Changed After the Latozinemab Trial Failure - Yahoo Finance
Will Alector Inc. (0Z2) stock announce special dividendTreasury Yields & AI Powered Market Entry Ideas - Newser
How supply shortages influence Alector Inc. (0Z2) stockQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
Arnon Rosenthal Sells 104,347 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
Sara Kenkare-Mitra Sells 41,687 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
What valuation ratios show for Alector Inc. (0Z2) stockTrade Signal Summary & Daily Technical Forecast Reports - Newser
How Alector Inc. (0Z2) stock compares with top peersBreakout Watch & High Yield Stock Recommendations - Newser
Will Alector Inc. (0Z2) stock benefit from Fed rate cutsWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
Alector CEO Rosenthal sells $116k in shares By Investing.com - Investing.com South Africa
Alector chief business officer sells $41,717 in stock By Investing.com - Investing.com South Africa
Alector principal accounting officer Wong-Sarad sells $9k in stock - Investing.com Canada
Alector: president Kenkare-Mitra sells $46k in shares By Investing.com - Investing.com Nigeria
Alector CEO Rosenthal sells $116k in shares - Investing.com India
Alector: president Kenkare-Mitra sells $46k in shares - Investing.com
Officer Wong-Sarad Surrenders 8,056 Of Alector Inc [ALEC] - TradingView — Track All Markets
ALEC SEC FilingsAlector 10-K, 10-Q, 8-K Forms - Stock Titan
Is Alector Inc. (0Z2) stock in buy zone after pullback2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Will Alector Inc. (0Z2) stock draw ESG focused fundsQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Is Alector Inc. (0Z2) stock supported by strong fundamentalsJuly 2025 Breakouts & Long-Term Safe Investment Ideas - Newser
Alector to Participate in the Bank of America CNS Therapeutics Conference - The Manila Times
CEO Rosenthal Files To Sell 92,427 Of Alector Inc [ALEC] - TradingView — Track All Markets
Will Alector Inc. stock outperform tech sector in 2025Quarterly Profit Summary & Consistent Income Trade Ideas - BỘ NỘI VỤ
Alector (NASDAQ:ALEC) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
How rising interest rates impact Alector Inc. stockRate Cut & AI Optimized Trade Strategies - BỘ NỘI VỤ
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):